Cipla | Company Profile
Contact Information
Industry & Market
Company Metrics
Funding Information
Headcount Distribution
By Department
Department Breakdown
Technology Stack
Analytics & Tracking
Development
Video & Media
Email & Communication
Keywords & Focus Areas
Cipla
Overview
Cipla Limited is a prominent Indian multinational pharmaceutical company, founded in 1935 in Mumbai. Originally named Chemical Industrial & Pharmaceutical Laboratories Ltd., it rebranded to Cipla in 1984. The company operates over 40 manufacturing facilities worldwide and has a presence in 86 countries, making it the third-largest drug producer in India. Cipla is dedicated to making medicines accessible and affordable, a mission inspired by its founder's vision.
Cipla offers a wide range of pharmaceutical formulations, including treatments for respiratory diseases, cardiovascular conditions, diabetes, and more. The company is known for its generic drugs, including complex generics and biosimilars, and has made significant contributions to the fight against HIV/AIDS by producing affordable antiretroviral drugs. Cipla also plays a role in COVID-19 response with products like rapid antibody test kits and antiviral drugs. With a strong research and development division, Cipla continues to innovate and expand its product offerings while serving a diverse customer base, including healthcare professionals and global health organizations.
Basic Information
Industry | pharmaceuticals |
---|---|
Founded | 1935 |
Revenue | 3.2B |
Headquarters | Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Mumbai, Maharashtra, 400013, India |
Languages | English |
Alexa Ranking | 164864 |
Contact Details
- Phone: +91 22248 26000
- Website: cipla.com
- LinkedIn: linkedin.com/company/cipla
Key Focus Areas & Initiatives
- Pharmaceuticals & active pharmaceutical ingredients
- Pharmaceutical manufacturing
- Biosimilar market expansion
- Active pharmaceutical ingredients
- Biosimilar market growth
- Biosimilar commercialization
- Generic medicines
- Biopharmaceuticals
- Biosimilar drugs
- Medicines accessibility
- Biosimilar research
- Biosimilar market
- Biosimilar manufacturing process
- Respiratory drugs
- Biosimilar innovation
- Biosimilar clinical trials
- Drug delivery systems
- Biotechnology
- Biosimilar development
- Bioscience
- Anti-retroviral drugs
- Drug development
- Biosimilars
- Biosimilar portfolio
- Biosimilar licensing
- Biosimilar partnerships
- Biosimilar strategy
- API production
- R&D innovation
- Biosimilar pipeline development
- Biosimilar product launch
- Healthcare
- Biosimilar pipeline
- Oncology treatments
- Biotech
- Biosimilar regulatory approval
- API manufacturing
- Global healthcare
- B2B
- Government
- Services
- Retail
- Patient care
- Innovation
- Sustainability
- Oncology
- Digital health
- Personal care
- Medical
- Health care
- Health, wellness & fitness
- Hospital & health care
- Environmental services
- Renewables & environment
- Information technology & services
Technologies Used
- Amazon AWS
- Apache
- Bootstrap Framework
- ExactTarget
- Gmail
- Google Analytics
- Google Apps
- Google Font API
- Google Tag Manager
- Microsoft Azure
- Microsoft Office 365
- Microsoft Sharepoint
- Mobile Friendly
- Outlook
- React Redux
- Remote
- SuccessFactors (SAP)
- WordPress.org
- YouTube
- reCAPTCHA